Privia Health Group Inc
NASDAQ:PRVA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
16.09
24.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Privia Health Group Inc
Privia Health Group Inc
Cost of Revenue
Privia Health Group Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Privia Health Group Inc
NASDAQ:PRVA
|
Cost of Revenue
-$1.5B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cost of Revenue
-$8.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cost of Revenue
-$6.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cost of Revenue
-$316.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
|
Cigna Corp
NYSE:CI
|
Cost of Revenue
-$206.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cost of Revenue
-$9.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-9%
|
|
Privia Health Group Inc
Glance View
Privia Health Group, Inc. engages in healthcare services. The company is headquartered in Arlington, Virginia and currently employs 810 full-time employees. The company went IPO on 2021-04-29. The firm collaborates with medical groups, health plans, and health systems. Its platform is purpose-built, organizing physicians into primary-care centric networks bolstered by physician governance, and promotes a culture of physician leadership. The Privia Platform is powered by end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into a seamless interface and workflow that manages all aspects of Privia Physicians provision of healthcare services.
See Also
What is Privia Health Group Inc's Cost of Revenue?
Cost of Revenue
-1.5B
USD
Based on the financial report for Dec 31, 2023, Privia Health Group Inc's Cost of Revenue amounts to -1.5B USD.
What is Privia Health Group Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-20%
Over the last year, the Cost of Revenue growth was -22%. The average annual Cost of Revenue growth rates for Privia Health Group Inc have been -27% over the past three years , -20% over the past five years .
You don't have any saved screeners yet
